Rubicon Research Ltd. engages in the manufacturing and export of formulations spanning a diverse range of dosage forms and therapeutic areas. Its products are utilized in analgesics, hypokalemia, skeletal muscle relaxants, metabolic, gastrointestinal, CVS, CNS, NRT and immunosuppressant areas. The company was founded by Maharukh T. Rustomjee, Pratibha Sudhir Pilgaonkar, and Sudhir Dhirendra Pilgaonkar on May 6, 1999 and is headquartered in Thane, India.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rubicon Research Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Rubicon Research Ltd. market cap is 161.42B.
What is the 52-week high for Rubicon Research Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rubicon Research Ltd. 52 week high is 1,015.70 as of May 26, 2026.
What is the 52-week low for Rubicon Research Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rubicon Research Ltd. 52 week low is 570.75 as of May 26, 2026.
What is Rubicon Research Ltd. stock price today?
Rubicon Research Ltd. stock price today is 974.90.
What was Rubicon Research Ltd. stock price yesterday?
Rubicon Research Ltd. stock price yesterday was 943.60.
What is the Price-to-Book ratio of Rubicon Research Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Rubicon Research Ltd. P/B ratio is 13.4934.
What is the 50-day moving average of Rubicon Research Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Rubicon Research Ltd. 50-day moving average is 882.28.